Evidence map›Paper›PMID 36927871›Full record

ArticleScientific reports2023

Gut microbiome signatures of Yorkshire Terrier enteropathy during disease and remission.

Pavlos G Doulidis, Alexandra I Galler, Bela Hausmann, David Berry, Alexandro Rodríguez-Rojas, Iwan A Burgener

Open access · goldFull text read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Fecal miRNA Profiling of Yorkshire Terrier Enteropathy.International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Adhesion ofVeterinary sciences · 2024
    Article
  9. Effects of Chenpi (Frontiers in microbiology · 2024
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Pavlos G DoulidisDepartment for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
Alexandra I GallerDepartment for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
Bela HausmannJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
David BerryJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Alexandro Rodríguez-RojasDepartment for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
Iwan A BurgenerDepartment for Small Animal Internal Medicine, Clinic for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria. Iwan.Burgener@vetmeduni.ac.at.
University of Veterinary Medicine Vienna · ATMedical University of Vienna · AT

Funding

Marie Curie 898858
6 · The paper itself

Abstract

The role of the gut microbiome in developing Inflammatory Bowel Disease (IBD) in humans and dogs has received attention in recent years. Evidence suggests that IBD is associated with alterations in gut microbial composition, but further research is needed in veterinary medicine. The impact of IBD treatment on the gut microbiome needs to be better understood, especially in a breed-specific form of IBD in Yorkshire Terriers known as Yorkshire Terrier Enteropathy (YTE). This study aimed to investigate the difference in gut microbiome composition between YTE dogs during disease and remission and healthy Yorkshire Terriers. Our results showed a significant increase in specific taxa such as Clostridium sensu stricto 1, Escherichia-Shigella, and Streptococcus, and a decrease in Bacteroides, Prevotella, Alloprevotella, and Phascolarctobacterium in YTE dogs compared to healthy controls. No significant difference was found between the microbiome of dogs in remission and those with active disease, suggesting that the gut microbiome is affected beyond clinical recovery.

Indexed as

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesMicrobiotaAnimalsBacteroidetesDogsHumans

Identifiers

PMID36927871
PMCPMC10018597
OpenAlexW4327624178

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read12
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.